Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07417566 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of DC6001 Tablet in Healthy Chinese Adult Subjects

Name: A Study of DC6001 Tablet in Healthy Chinese Adult Subjects — clinical trial record (NCT07417566)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorHeronova Pharmaceuticals

Started2026-01-01

View on ClinicalTrials.gov ↗

Heronova Pharmaceuticals

3 trials monitored

See 1 trial at risk

This study adopts a randomized, double-blind, parallel placebo-controlled dose-escalation design, consisting of two parts: Part 1 includes a single ascending dose (SAD) study plus a food effect (FE) study, and Part 2 is a multiple ascending dose (MAD) study.

Trial Details

NCT Number	NCT07417566
Lead Sponsor	Heronova Pharmaceuticals
Conditions	Stargardt Disease
Enrollment	76 participants
Start Date	2026-01-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-18